Article Versions Notes

Tay BWR, Huang DQ, Mark M, Thong NW, Guan Huei L, Gee LS, Cheng LH, Mei LY, Thurairajah P, Chen LJ, et al. Comparable Outcomes in Early Hepatocellular Carcinomas Treated with Trans-Arterial Chemoembolization and Radiofrequency Ablation. Biomedicines. 2022; 10(10):2361. https://doi.org/10.3390/biomedicines10102361

Tay, Benjamin Wei Rong, Daniel Q. Huang, Muthiah Mark, Neo Wee Thong, Lee Guan Huei, Lim Seng Gee, Low How Cheng, Lee Yin Mei, Prem Thurairajah, Lim Jia Chen, and et al. 2022. "Comparable Outcomes in Early Hepatocellular Carcinomas Treated with Trans-Arterial Chemoembolization and Radiofrequency Ablation" Biomedicines 10, no. 10: 2361. https://doi.org/10.3390/biomedicines10102361

Tay, B. W. R., Huang, D. Q., Mark, M., Thong, N. W., Guan Huei, L., Gee, L. S., Cheng, L. H., Mei, L. Y., Thurairajah, P., Chen, L. J., Ng, C. H., Lim, W. H., Tan, D. J. H., Maureen, D. C., Alfred, K. W. C., Ganpathi, I. S., Seng, T. P., & Young, D. Y. (2022). Comparable Outcomes in Early Hepatocellular Carcinomas Treated with Trans-Arterial Chemoembolization and Radiofrequency Ablation. Biomedicines, 10(10), 2361. https://doi.org/10.3390/biomedicines10102361